Early brain vulnerability in Wolfram syndrome by Hershey, Tamara et al.




Early brain vulnerability in Wolfram syndrome
Tamara Hershey
Washington University School of Medicine in St. Louis
Heather M. Lugar
Washington University School of Medicine in St. Louis
Joshua S. Shimony
Washington University School of Medicine in St. Louis
Jerrel Rutlin
Washington University School of Medicine in St. Louis
Jonathan M. Koller
Washington University School of Medicine in St. Louis
See next page for additional authors
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Hershey, Tamara; Lugar, Heather M.; Shimony, Joshua S.; Rutlin, Jerrel; Koller, Jonathan M.; Perantie, Dana C.; Paciorkowski, Alex R.;
Eisenstein, Sarah A.; Permutt, M. Alan; and Washington University Wolfram Study Group, ,"Early brain vulnerability in Wolfram
syndrome." PLoS One.7,7. e40604. (2012).
http://digitalcommons.wustl.edu/open_access_pubs/1375
Authors
Tamara Hershey, Heather M. Lugar, Joshua S. Shimony, Jerrel Rutlin, Jonathan M. Koller, Dana C. Perantie,
Alex R. Paciorkowski, Sarah A. Eisenstein, M. Alan Permutt, and Washington University Wolfram Study
Group
This open access publication is available at Digital Commons@Becker: http://digitalcommons.wustl.edu/open_access_pubs/1375
Early Brain Vulnerability in Wolfram Syndrome
Tamara Hershey1,2,3*, Heather M. Lugar1, Joshua S. Shimony3, Jerrel Rutlin1, Jonathan M. Koller1,
Dana C. Perantie1, Alex R. Paciorkowski5, Sarah A. Eisenstein1, M. Alan Permutt4, and the Washington
University Wolfram Study Group"
1Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, United States of America, 2Department of Neurology, Washington University
School of Medicine, St. Louis, Missouri, United States of America, 3Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, United States
of America, 4Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, 5Department of Neurology,
University of Washington, St. Louis, Missouri, United States of America
Abstract
Wolfram Syndrome (WFS) is a rare autosomal recessive disease characterized by insulin-dependent diabetes mellitus, optic
nerve atrophy, diabetes insipidus, deafness, and neurological dysfunction leading to death in mid-adulthood. WFS is caused
by mutations in the WFS1 gene, which lead to endoplasmic reticulum (ER) stress-mediated cell death. Case studies have
found widespread brain atrophy in late stage WFS. However, it is not known when in the disease course these brain
abnormalities arise, and whether there is differential vulnerability across brain regions and tissue classes. To address this
limitation, we quantified regional brain abnormalities across multiple imaging modalities in a cohort of young patients in
relatively early stages of WFS. Children and young adults with WFS were evaluated with neurological, cognitive and
structural magnetic resonance imaging measures. Compared to normative data, the WFS group had intact cognition,
significant anxiety and depression, and gait abnormalities. Compared to healthy and type 1 diabetic control groups, the
WFS group had smaller intracranial volume and preferentially affected gray matter volume and white matter microstructural
integrity in the brainstem, cerebellum and optic radiations. Abnormalities were detected in even the youngest patients with
mildest symptoms, and some measures did not follow the typical age-dependent developmental trajectory. These results
establish that WFS is associated with smaller intracranial volume with specific abnormalities in the brainstem and
cerebellum, even at the earliest stage of clinical symptoms. This pattern of abnormalities suggests that WFS has a
pronounced impact on early brain development in addition to later neurodegenerative effects, representing a significant
new insight into the WFS disease process. Longitudinal studies will be critical for confirming and expanding our
understanding of the impact of ER stress dysregulation on brain development.
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Introduction
Wolfram syndrome (WFS) is a rare (1 in ,770,000) autosomal
recessive genetic disease characterized by early childhood onset
insulin dependent diabetes, optic nerve atrophy, vision and
hearing loss, diabetes insipidus and neurodegeneration, resulting
in death in middle adulthood, typically due to brainstem atrophy-
induced respiratory failure [1]. There are no interventions to slow
or stop this devastating deterioration. However, much is known
about the mechanisms underlying these effects. The causative gene
(WFS1) was identified by our group in 1998 [2], and a number of
loss-of-function mutations have been described [2–4]. Cell [5] and
animal models [6] have determined that WFS1 encodes an
endoplasmic reticulum (ER) membrane-embedded protein called
wolframin [7], and that mutant forms of the WSF1 protein lead to
disturbances of ER calcium homeostasis, driving ER stress-
mediated apoptosis [8–10]. This process kills insulin producing
pancreatic b-cells, leading to diabetes. WFS1 is also expressed
throughout the brain, and cell death via ER stress is thought to
underlie neurodegeneration in WFS [4,11].
Although there are no current treatments for this disease, agents
to treat ER stress-mediated apoptosis are currently in development
[12,13]. ER stress also has been implicated in a number of
neurodegenerative (Alzheimer disease, Parkinson disease, amyo-
trophic lateral sclerosis), endocrine (Type 1 and Type 2 diabetes)
and cardiovascular (heart disease, atherosclerosis) diseases [14].
Thus, WFS may provide a useful model for examining the impact
of ER stress on the brain, particularly during neurodevelopment
[15]. In contrast to the polygenic, multifactorial etiology of other
diseases, WFS’s clinical features are due to deficiency of a single
protein, wolframin. Research into this monogenic disease may
provide critical insight into more genetically complex forms of
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diabetes and neurodegenerative diseases in which ER stress is
implicated. Successful interventions for WFS may then provide the
proof-of principle for using similar agents to treat more common
and complex forms of ER stress-related diseases in the future. This
innovative model has been followed successfully in other
conditions (e.g. bone disorders [16–20]). An early step towards
this important goal is to establish the characteristic neurodegen-
erative changes in WFS.
Our current knowledge of WFS-related brain changes come
primarily from clinical exams and post-mortem neuropathological
case studies of severely affected individuals with WFS. These
studies found abnormalities in multiple regions of the brain,
including hypothalamus, pituitary, pons, inferior olivary nucleus,
lateral geniculate nucleus, thalamus, optic nerve, optic tract and
cerebellum [1,3,21–31]. Motor, cognitive and psychiatric dysfunc-
tion have been reported in advanced WFS, but quantified,
systematic assessments have not been performed in relatively early
WFS. Clinical retrospective survey data suggest that neurological
features occur late (15–30 yrs of age) in the disease process [32,33],
but these patients were not directly assessed with standardized,
objective methodology or compared to age-equivalent controls
[23,30,31]. Thus, it is not known at what stage of the disease these
potential brain structural or functional changes or subsets of
changes emerge, become clinically significant, or how structural
and functional changes relate to each other and to overall disease
severity.
An understanding of the natural history of neurological
changes in WFS will be important in assessing the validity of
animal models of WFS, for developing interventions for
neurological changes, as well as addressing questions about
how WFS1 mutations and ER stress affects neurodevelopmental
processes. Thus, the goal of the current study is to determine the
regional pattern of neuroanatomical abnormalities in WFS across
a range of disease duration and imaging modalities. To address
this gap in the literature, we studied individuals with WFS at the
earliest stage of disease possible and compared them to both age
and gender equivalent healthy and type 1 diabetic controls.
Thus, we were able to survey the brain’s structural and
functional integrity across a range of very early to more
advanced disease using sophisticated in vivo structural brain
imaging techniques and neurobehavioral measurements.
Methods
Participants with WFS were evaluated clinically by a team of
investigators including a pediatric neurologist, audiologist and
ophthalmologist. Patients then performed neuropsychological
testing and MRI scans and completed self-report questionnaires
if over 16 (parents completed parent-report if 16 or younger) about
psychiatric and behavioral issues. Control subjects completed MRI
scans only.
Subjects
WFS. Individuals withWFS who registered on theWashington
University WFS Registry (http://wolframsyndrome.dom.wustl.
edu/medical-research/Wolfram-Syndrome-Home.aspx), who
were under the age of 30, aware of their diagnosis and able to travel
were invited to participate. Further inclusion criteria were the
diagnosis of diabetes mellitus and optic nerve atrophy before 18
years of age or genetic confirmation of a WFS1 mutation.
Controls. MRI comparison groups consisted of age equiva-
lent healthy controls (HC) and individuals with type 1 diabetes
mellitus (Type 1 Controls or T1C) scanned at Washington
University as part of other studies. Youth with T1C were recruited
from the Pediatric Diabetes Clinic at St. Louis Children’s Hospital
and Washington University School of Medicine in St. Louis. Non-
diabetic controls were either healthy siblings of the diabetic
patients or from the community. T1C were excluded for
diagnosed psychiatric disorder, significant neurological history
not due to diabetes, known premature birth (,36 weeks gestation)
with complications, psychoactive medications, or physical limita-
tions that would interfere with testing. No T1C participants had
known retinopathy, nephropathy or neuropathy at the time of
testing. Controls were excluded for current or past history of
neurological and psychiatric diagnoses or other significant health
conditions. All subjects underwent MRI scans for research
purposes only, not for any clinical indication.
Ethics Statement. For all participants, informed consent was
obtained prior to participation and the study was approved by the
Human Research Protection Office at Washington University in
St. Louis. Children under age 18 provided assent, and their
parent/guardian provided written consent.
Cognitive and Behavioral Testing
Before beginning testing, WFS participants were determined to
have blood glucose levels above 70 mg/dl. Standardized IQ,
cognitive and behavioral measures were administered. Each
patient’s performance was compared to normative data for their
age and gender.
Vocabulary and Similarities subtests from The Wechsler Abbrevi-
ated Scale of Intelligence (WASI) [34] were used to estimate a
verbal intelligence quotient (IQ). The computerized Conners’
Continuous Performance Test II (CPT II) [35] was used to determine
sustained attentional capacity. The Letter Number Sequencing [36,37]
task from the Wechsler Child or Adult Intelligence Scales was used
to assess verbal working memory. The Children’s or Adult California
Verbal Learning Test (CVLT) [38,39] was used to assess verbal
learning and memory. The Achenbach Child Behavior Checklist or Adult
Self Report (CBCL, ages 6–16; ASR; ages 16 and above) [40] was
used to assess parent and self-rated behavioral and mood status
across the Internalizing Domain (Affective, Anxiety and Somatic
Problems) and the Externalizing Domain (Attention Deficit/
Hyperactivity, Oppositional Defiant and Conduct Problems).
Neuroimaging
Before beginning scanning, WFS and T1C participants were
determined to have blood glucose levels above 70 mg/dl. Scans
were acquired on one of three Siemens 3T Tim Trio MRI
scanners at Washington University. All three scanners had the
same hardware and software, and they are each checked by
Siemens maintenance personnel every 3 months to confirm that
the machines are running in accordance with their recommenda-
tions. In addition, cross-calibration scanning on 15 normal control
children from another study (unpublished data) using similar
sequences as ours has shown a high degree of consistency and
absolute difference in regional DTI FA (average r = .96, average
mean difference in FA =2.3%) and Freesurfer-derived volumes
(average r = .87, average mean difference in volumes = 1.7%).
These metrics are consistent with the literature of Freesurfer
performance across different scanners [41,42].
The following sequences were acquired: T1-weighted MPRAGE
sequence: Sagittal acquisition, TR=2400, TE= 3.16, TI = 1000,
voxel resolution = 16161mm, Time= 8:09 min. T2-weighted MR:
Sagittal acquisition, TR=3200, TE=455, voxel resolu-
tion= 16161mm, Time=4:43 min. T2 FLAIR: Transverse acqui-
sition, TR=9190, TE=98, TI = 2500, voxel resolu-
tion= .866.8663mm, Time= 3:59 min. This sequence was
acquired for the WFS group only for clinical neuroradiological
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reading. Diffusion Tensor Imaging (DTI): The echo planar sequence
consisted of 27 directions with the b-values ranging from 0 to
1400 s/mm2. Transverse acquisition, TR=12300, TE=108, voxel
resolution = 1.9861.9862 mm, Time=5:44 min. The DTI se-
quences in the control groups varied slightly in the number of
b = 0 scans acquired, but their scans had the same resolution and
range of b-values as theWFSgroup (with the exception of 16 subjects
scanned with b-values only up to 1000 rather than 1400).
Methods were selected to provide complementary levels of
information. The ROI method has several advantages over voxel-
wise analyses – it minimizes the risk of type 1 error, avoids the
many statistical assumptions of voxel-wise analyses, and allows for
tailoring ROIs to avoid partial volume effects, thus reducing the
impact of imperfect registration procedures [43]. On the other
hand, voxel-wise or vertex-wise analyses consider all of the
imaging space without regard for arbitrary or unreliable bound-
aries. We employ both approaches here for volumes and for
diffusion tensor measures in order to provide a comprehensive
view of the regional brain abnormalities in WFS. We pay
particular attention to findings that are similar across imaging
modalities and analysis methods.
Regional Gray and White Matter Volumes
To determine regional gray and white matter brain volumes
from anatomically defined regions, we used the semi-automatic
segmentation program Freesurfer (v5.0) [44]. This program
automatically reconstructed the brain from surface and volumetric
registration to an atlas to quantify gray and white matter volumes.
To minimize the opportunity for false positives, we focused on a
select number of regions (n = 13: brainstem, cerebellar gray
matter, cerebellar white matter, thalamus, pallidum, corpus
callosum, hippocampus, amygdala, caudate, putamen, accumbens,
total cortical gray, total cortical white matter). Left and right
volumes were averaged and corrected for intracranial volume
(ICV or volume within the skull, derived from Freesurfer)
according to validated methods [45]. A Bonferonni multiple
comparison correction procedure was applied to determine
significance, after controlling for age and gender.
Brainstem Segmentation Volumes
To examine the brainstem, known to be particularly affected in
advanced WFS, in more detail, we performed manual segmenta-
tion of the Freesurfer-generated brainstem according to published
criteria [46]. The brainstem was divided into midbrain, pons and
medulla using anatomical landmarks. The border between the
midbrain and the pons was defined by a plane touching both the
upper rim of the pons and the inferior border of the inferior
colliculus. The border between the pons and medulla was defined
by a plane parallel to that of the midbrain-pons border, touching
the lower rim of the pons. The MR images were rotated to align
the brainstem so that these borders were transverse slices, and the
Freesurfer-generated brainstem was segmented according to those
slices. Two raters independently chose these landmarks (intraclass
correlation coeffecients [ICCs] were above .98 for all landmarks)
and the chosen rotations were averaged. Analyses were normalized
using ICV and controlled for age and gender.
Surface-based Cortical Measurements
To explore cortical metrics in a landmark-independent manner,
we reconstructed and segmented individual subjects’ cortical
surfaces using Freesurfer (v5.0) [47–49]. The cortical gray/white
matter border and pial surfaces were identified in each subject,
and a triangular tessellation was applied across the cortical surface.
Using these cortical maps, we calculated multiple surface-based
measurements at each vertex of the triangular mesh. These
included cortical thickness (the distance between the white and pial
surfaces), surface area (the sum of the areas of the triangles
connected to a vertex) and gray matter volume (the product of
cortical thickness and surface area). A whole brain, vertex-by-
vertex group comparison was conducted using Freesurfer’s group
analysis tool, Qdec. Effects between our patient group and our
controls (healthy and T1DM controls collapsed due to restrictions
in the statistical modeling of this software) were calculated for each
hemisphere by general linear model (GLM) at each vertex for
thickness, area, and volume, while controlling for age and gender
(thickness), or age, gender, and ICV (for area and volume). Data
were smoothed using a full width/half-maximum Gaussian kernel
of 15 mm and corrected for multiple comparisons using Monte
Carlo permutation cluster analyses with a significance threshold of
p,.05.
Whole Brain Voxel-wise Analyses of Gray and White
Matter Volumes
Voxel-based morphometry (VBM) was performed with statisti-
cal parametric mapping software (SPM8; Wellcome Department
of Cognitive Neurology, www.fil.ion.ucl.ac.uk). Images were
simultaneously normalized to Montreal Neurological Institute
(MNI) space using non-linear transforms, corrected for intensity
inhomogeneity, and segmented into gray matter, white matter,
and CSF. We used custom tissue probability maps based on our
subjects instead of the default SPM maps to improve segmentation
[50,51]. Gray and white segments were modulated to produce
images representing gray and white matter volume [50]. After this
processing, voxel dimensions were 26262 mm. Modulated
segments were smoothed with a 12 mm full width half maximum
Gaussian kernel to promote normality of residuals [52]. Voxels
with segmented intensities less than 0.1 were masked out with an
absolute threshold to reduce voxels possibly belonging to other
tissue classes and since these voxels are less likely to adhere to
assumptions of normality [53]. Images were analyzed by SPM8,
comparing groups (WFS vs. all controls) at each voxel, which
results in statistical parametric maps (SPMs) on which every
voxel’s intensity corresponds to a t value. The SPMs were then
thresholded to show only voxels with t values corresponding to
uncorrected p,.001. The probability of resulting clusters was
corrected for multiple comparisons taking into account non-
uniformity due to intrinsically inhomogeneous smoothness using
the stat_threshold script from Worsley’s fmristat package [54,55].
Age and gender were removed as covariates from all models.
Independent sample t-tests were performed for comparisons
between groups, defining contrasts in each direction (e.g., WFS
. controls; WFS , controls). Cluster-level multiple comparison
and smoothness corrected p values ,.05 were considered
significant.
General Analysis Approach to White Matter
Microstructural Integrity
DTI images were atlas-transformed and measures of white
matter microstructural integrity (fractional anisotropy or FA and
mean diffusivity or MD) were computed [56,57]. These measures
are sensitive indicators of white matter injury [58] and can detect
changes even when standard T2-weighted images appear normal
and the volumes of white matter regions are similar [59–63]. We
computed FA and MD volumes from native space data and
analyzed these images in two complementary ways, to balance the
desire to control type 1 error while fully exploring our unique
dataset.
Brain Vulnerability in Wolfram Syndrome
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Regions of Interest DTI Analyses
Regions were selected based on a well-established DTI atlas
[64] and were checked by a neuroradiologist with expertise in
DTI. We then compared the placement of the regions on each
subject’s colorized FA map, T1 and T2 images simultaneously.
ROIs were shifted by a few voxels as necessary to better conform
to each individual’s native anatomy. Finalized regions were then
applied to FA and MD volumes. Raters have established ICC’s
above .90 for FA and MD values for all ROIs. To minimize the
opportunity for false positives, we focused on a select number of
regions (n = 10: cerebellum, optic radiation, posterior limb of the
internal capsule, corpus callosum [average of 3 regions], centrum
semiovale, thalamus, putamen, hippocampus, cerebellar peduncle,
and pons), average left and right volumes, applied Bonferroni
multiple comparison correction (.05/10 or p,.005), and con-
trolled for age and gender.
Tract-Based Spatial Statistics (TBSS) DTI Analyses [65]
Despite the advantages of the ROI method of DTI, we also used
voxel-wise exploratory analyses of our DTI data to confirm our
ROI findings but also to be open to white matter effects in other
locations without regard for anatomical boundaries. Diffusion
weighted images were internally motion corrected using 9-
parameter affine (rigid body + scanner axis stretch) registration
using in-house developed software. Then, using each individual’s
motion-corrected, aligned, and averaged DWI data set, BET
(FMRIB Brain Extraction Tool) was used to compute a brain
mask, and FDT (FMRIB diffusion toolbox) was used to compute
FA maps. To create a target template for registration, a subset of
individuals were chosen from the entire subject pool to provide an
even distribution of males and females and ages. FA images in the
target group were then nonlinearly aligned to 16161 mm space
and to each other. The target image was the image that requires
the least amount of warping for all other FA images to align to it.
All FA images in the entire subject pool were then nonlinearly
aligned to each other in 16161 mm space and to the target image.
The target image was affine-aligned into MNI152 standard space,
and every FA image was then transformed into 16161 mm
MNI152 space. A mean FA image was calculated and used to
produce the mean FA skeleton to represent the center of white
matter tracts. FA images were projected onto the mean FA
skeleton and thresholded at FA=0.2 for voxel-wise analyses.
Mean, axial and radial diffusivity images were also calculated and
all were analyzed with Randomise, a permutation-based multiple
comparisons corrected statistical approach [66]. Age and gender
were co-varied in analyses comparing groups (WFS vs all controls).
Statistical Analyses of Neuroimaging Data
For all region-based analyses we performed univariate analyses
of each region, with group as the independent variable (HC, T1C,
WFS) with age and gender covaried. We were then able to
determine if control groups differed on regional values. We
applied a Bonferroni correction for multiple comparisons within
imaging modalities. For gray and white matter volumes of interest,
the criterion for significance was p,.0038 (.05/13). For DTI
regions of interest, the criterion for significance was p,.005 (.05/
10). Regions that survived correction from any analyses were
examined for differences between groups with post-hoc compar-
isons. For voxel or vertex-wise analyses, we compared all WFS vs
all controls, to simplify the statistical models needed (and since no
regional differences were found between control groups) and to
maximize power. Each analysis used software-specific multiple
comparison correction procedures described above, and age and
gender were removed as covariates from all models.
Results
General Clinical Information for WFS Group
Patients with WFS ranged in age from 5.9 to 25.8 (mean=14.6,
SD=6.1; 6 male 8 female). All had confirmed mutations on the
WFS1 gene and had insulin dependent diabetes mellitus (average
age of onset = 5.8 years; range 2–14 years of age). All but one had
been diagnosed with optic nerve atrophy at the time of assessment
(average age at diagnosis = 9.3 years; range 3 to 16 years of age);
10/14 were being treated for diabetes insipidus (average age of
diagnosis = 10.1 years; range 2.5 to 17 years of age). WFS
individuals had a wide range of duration of diabetes mellitus
(range 0.75–21.7 years, mean=8.8, SD=6.0), optic atrophy
(range 1.1–15.2 years; mean= 5.9, SD=4.9) and diabetes
insipidus (range .25 to 11.9 years; mean=5.2, SD=4.5). Younger
individuals tended to have shorter duration of all of these
symptoms. Standard ophthalmological tests revealed that 13/14
WFS participants had color vision impairment ranging from mild
to severe. All had abnormally thin retinal nerve fiber layers on
optical coherence tomography (OCT). Audiometric tests revealed
that 7/14 patients had evidence of hearing loss. Clinical
neurologic exams revealed that the most common abnormalities
were horizontal nystagmus and difficulty tandem walking (8/14
subjects). Several subjects (5/14) had impaired vibration sense, and
other more subtle motor abnormalities were also noted, including
increased lower extremity tone, intention tremor, and brisk deep
tendon reflexes in one subject each. These clinical findings confirm
that our WFS group ranged from very mild to moderate severity of
symptoms on standard clinical measures.
Cognitive/Behavioral Information
Some individuals with WFS, either due to language (non-native
English speaker, n = 1) or sensory issues (significant vision
problems, n = 2), could not complete all of the tasks. However,
the rest of the WFS group performed above the average range for
verbal intelligence (Verbal IQ mean percentile = 77, SD=15),
and within the average range for verbal learning and memory
(CVLT Total Recall, trials 1–5, mean percentile = 57, SD=25;
CVLT Long Delay Free Recall mean percentile = 55, SD=25),
and attention (CPT Detectability mean percentile = 41, SD=27).
In contrast, on a comprehensive psychological questionnaire,
participants or parents reported more symptoms in the Internal-
izing Domain which includes depression, anxiety and somatic
symptoms (mean percentile for symptoms= 65.6, SD=32) than in
the Externalizing Domain which includes conduct disorders,
impulsivity and aggression (mean percentile for symptoms= 33.1,
SD=24; paired t-test, t(13) = 3.85, p = .002). Five individuals had
clinically significant symptoms (T score above 69) and 1 had
clinically borderline symptoms (T score 65–69) in the Internalizing
domain, but only 1 had clinically significant symptoms in the
Externalizing Domain. Eleven WFS subjects had blood glucose
levels recorded at the time of testing; levels ranged from 124 to 325
(mean=225 mg/dl, SD=65).
Neuroimaging
MRIs were acquired on 11 individuals with WFS. The
remaining 3 patients had contraindications for MR and could
not be safely scanned (cochlear implant, n = 2; bladder neuro-
stimulator, n = 1). Two of the 11 had clinically normal scans; the
other 9 had clinically detectable abnormalities on MR similar to
those noted in case studies of WFS (i.e. 5 had elevated T2 signal
in pons; 7 had elevated T2 signal in frontal and occipital cortex)
and individuals with diabetes insipidus (i.e. 5 had absent or
reduced normal pituitary bright spot on T1).
Brain Vulnerability in Wolfram Syndrome
PLoS ONE | www.plosone.org 4 July 2012 | Volume 7 | Issue 7 | e40604
De-identified scans from age and gender-equivalent HC and T1C
individuals were obtained for comparisons to the WFS group. These
subjects either had T1-weighted images (for gray and white matter
volume measures; HC, n=30; T1C, n= 22) or DTI scans (HC,
n=45; T1C controls, n= 10). Thirty-eight subjects had T1-weighted
scans and 12 had DTI scans on the first scanner, 25 (including the 11
WFS subjects) had T1-weighted scans and 38 (including the 11WFS)
had DTI scans on the second scanner and no subjects had T1-
weighted scans, and 16 had DTI scans on the third scanner. Within
DTI sequences, 50 subjects had b1400 and 16 had b1000 scans; 42
had 25 directions and 24 had 26 direction scans. The control groups
were not different in mean age or gender distribution from the WFS
group (Table 1). In both T1C andWFS groups, duration of diabetes
was highly correlated with age (r..80). The WFS group and the
larger T1C group (n=23 with T1-weighted MR) were not different
in mean duration of diabetes. However, the smaller T1C group
(n= 10 with DTI) had significantly shorter duration of diabetes than
theWFS group (Table 2). For T1C andWFS subjects, glucose values
were measured just before or just after scans, and ranged from 71–
337 for the T1C group (n=22) and 123–289 for the WFS group
(n= 8). Mean values were not different between groups (t-test, t = -
.74, p= .47; T1C mean=182 mg/dl, SD=70; WFS
mean=203 mg/dl, SD=62).
Regional Gray and White Matter Volumes
Overall, there was a significant effect of group (WFS, HC, T1C)
on intracranial volume (ICV) after correcting for age and gender
(F(2,58) = 5.9, p = .005). Post-hoc pair-wise comparisons revealed
that the WFS group had smaller ICV compared to the HC and
T1C groups (p,.004), but these control groups were not different
from each other (p = .91). Whole brain volume (defined as
everything inside the pial surface of the brain, excluding brainstem
and cerebellum) was also smaller in the WFS group (F(2,58) = 5.1,
p = .009), but after controlling for ICV, was similar across groups
(F(2,58) = 0.9, p = .38).
Out of 13 regions normalized for ICV, 5 had a main effect of
group at the p,.05 level; 3 of these survived multiple comparison
correction (p,.0038)(Table 3; Fig 1). These regions were brainstem
(F(2,58) = 22.5, p,.001), cerebellar gray matter (F(2,58) = 8.3,
p= .001) and cerebellar white matter (F(2,58) = 14.7, p,.001). In
all of these regions, the WFS group had smaller volumes than both
the HC and T1C (ps,.05), but the HC and T1C groups did not
differ from each other (p..05). In addition, even the youngest and
least affected WFS patients showed reduced volumes in these
regions compared to control groups.
Brainstem Segmentation Volumes
Volumes of brainstem segments (midbrain, pons, medulla) were
normalized for ICV. A repeated measures general linear model
analysis found, as expected, a main effect of diagnosis
(F(2,56) = 22.4, p,.001; WFS , T1C and HC) and a main effect
of segment (F(2,55) = 41.3, p,.001; pons . midbrain and
medulla) with age and gender as covariates. More interestingly,
we found a segmental volume by diagnosis interaction
(F(4,112) = 7.6, p,.001) that was still significant after also
covarying duration of diabetes (WFS vs T1C only, F(2,26) = 9.1,
p,.001). Post-hoc contrasts found that the WFS group volume
was significantly different from the control groups for all three
segments, but the effect was most striking in the pons (Fig 2A).
Before normalization, 10/11 WFS patients had reduced volume in
the pons compared to age equivalent controls. After normaliza-
tion, 8/11 WFS patients had reduced volume in the pons
compared to age equivalent controls (Fig 2B).
Surface-based Cortical Measurements
We examined cortical thickness, cortical area and cortical
volume (a product of thickness and area) between the combined
control group and the WFS group across the entire cortex. In
vertex-wise analyses, the WFS group had reduced thickness in
several regions after controlling for age and gender, and applying
multiple comparison corrections (Fig 3). In the left hemisphere,
WFS had reduced thickness in a precentral region (BA 6; cluster
size = 2311.73 mm2, cluster-wise p = .0008), a lingual region (BA
18; cluster size = 1676.56 mm2, cluster-wise p = .0113), and two
rostral middle frontal regions (BA 10; cluster-size = 3060.86 mm2,
cluster-wise p = .0001; BA 9; cluster size = 1422.12 mm2, cluster-
wise p = .0304). In the right hemisphere, there was also reduced
thickness in the WFS group in a rostral middle frontal region (BA
46; cluster size = 2320.65 mm2, cluster-wise p = .001). No clusters
from the surface analyses of surface area or volume had significant
group effects after multiple comparison correction.
Whole Brain Voxel-wise Analyses of Gray and White
Matter Volumes
VBM analyses of gray matter revealed that the WFS had
significantly less gray matter volume in the cerebellum. Two large
Table 1. Mean (6SD) age and gender distribution and clinical








Gender M/F 15/15 14/8 5/6
Age in years Mean 12.563.2 14.363.2 14.066.3
Range 7.6–18.7 7.1–19.0 5.9–25.8
Duration of diabetes in
years
Mean – 4.564.7 7.465.3
Range – .11–13.6 .75–16.2
Abbreviation. HC: healthy controls; T1C: diabetic controls; WFS: Wolfram
Syndrome group; SD: standard deviation.
There were no differences between groups for age (p = .23), gender (p = .51) or
duration of diabetes between T1C and WFS (p = .12).
doi:10.1371/journal.pone.0040604.t001
Table 2. Mean (6SD) age and gender distribution and clinical







Gender M/F 23/22 7/2 5/6
Age in years Mean 11.963.1 11.862.3 14.066.3
Range 7.0–17.7 7.1–14.2 5.9–25.8
Duration of diabetes in
years
Mean – .196.05 7.465.3
Range – .11–.25 .75–16.2
Abbreviation. HC: healthy controls; T1C: diabetic controls; WFS: Wolfram
Syndrome group; SD: standard deviation.
There were no differences between groups for age (p = .24) or gender (p = .28)
but there was a significant. difference in duration of diabetes between T1C and
WFS (p = .001).
doi:10.1371/journal.pone.0040604.t002
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clusters survived multiple comparison and smoothness correction,
covarying for age and gender: one in the right cerebellum
(p= 0.0008, 3278 voxels) and one in the left cerebellum
(p= .0125, 1740 voxels)(Fig 4A). There were no clusters in which
WFS had more gray matter volume than controls. VBM analyses of
white matter revealed that the WFS group had significantly lower
volumes in one very large cluster that included much of the
cerebellum bilaterally and extended through the brainstem and
subcortex (p,.001, 29678 voxels)(Fig 4B). An additional, much
smaller cluster was found in the parietal-occipital cortex (p= .0239,
243 voxels). There were no significant clusters in which the WFS
group had more white matter volume than controls.
Regions of Interest DTI Analyses
Placed regions were visually verified to not overlap with any of
the T2 signal abnormalities observed in WFS patients. Out of the
10 regions examined for DTI measures, 3 had a main effect of
group for FA and 3 had a main effect of group for MD measures at
the p,.05 level. Two FA regions (cerebellum: F(2,60) = 13.7,
p,.001; optic radiation: F(2,60) = 11.0, p,.001) and one MD
region (cerebellum: F(2,59) = 14.0, p,.001) survived multiple
comparison correction with age and gender as covariates (main
effect of group, p,.005) (Table 4). For FA in the optic radiations,
the WFS group was significantly different from the HC group
(p,.05), but not the T1C group (p= .18), and the two control
groups were different from each other (p,.05). For FA in the
cerebellum, the WFS group was significantly different from both
control groups (p,.003), but the control groups were not different
from each other (p = .37). For MD in the cerebellum, all three
groups were significantly different from each other (p,.001; post
hoc comparisons).
Tract-Based Spatial Statistics (TBSS) DTI Analyses
Significant reduction in FA was found in the WFS group across
a wide range of regions after controlling for age and gender and
correcting for multiple comparisons. The largest and most striking
clusters were found in the brainstem, cerebellum and optic
radiations (see Fig 4), consistent with the results from ROI
analyses. In addition, we detected widespread decreased FA in the
subcortical white matter, which is not thoroughly sampled by
ROIs. The WFS had reduced axial, but not radial, diffusivity in
the cerebellum and brainstem primarily, although differences were
seen across the brain to a lesser extent, similar to the FA results
(Fig 5).
Scanner and Sequence Differences in Neuroimaging Data
To assess any impact of differences in scanners, we performed
further analyses on the significant regions, restricting analyses to
only those subjects with data collected on the same 3T scanner.
For subcortical volumes (HC, n= 4, T1C, n= 10, WFS, n= 11)
and DTI measures (HC, n= 17, T1C, n= 9, WFS, n = 11)
analyses revealed the same pattern as our larger sample (main
effect of group; p,.001 for brainstem, cerebellar white, cerebellar
gray, cerebellar FA and MD, and optic radiation FA; group x
segment interaction for brainstem, p,.001). These results survive
multiple comparison correction and support the robustness of our
findings, suggesting that scanner and sequence variability within
our control groups did not bias the original results.
Discussion
We report quantitatively measured and regionally distinct
structural brain changes in early stage WFS. We found reduced
ICV, dramatically reduced regional volumes and altered white
matter microstructural integrity. The brainstem, cerebellum and
optic radiations were particularly affected in WFS compared to
both healthy controls and controls with type 1 diabetes (T1C).
Notably, decreased brainstem and cerebellum volumes (after
controlling for intracranial volume or ICV) were seen in almost all
individuals with WFS, regardless of age or duration of diabetes or
other features of the disease. These data together suggest that WFS
Table 3. Mean (6 SEM) volumes of brain regions in mm3, adjusted for age and gender.
Brain Region (mm3) HC (n=30) T1C (n =22) WFS (n=11) p value
Intracranial (ICV) 14816376134316 15096336127999 1358061692086 a,b .005
Whole brain 1029284694162 1045945689363 940183684097 a,b .009
Total cortical gray 538,74464231 53503064952 538,66066919 .84
Total cortical white 443,43964787 456,99765603 447,06667829 .19
Brainstem 20,5606343 19,9606401 16,2206560 a,b ,.001
Cerebellum white 15,6356326 14,7726382 12,2366534 a,b ,.001
Cerebellum gray 58,4196761 58,3146891 52,77161245 a,b .001
Thalamus 7,168692 7,1126107 6,5856150 a,b .005
Pallidum 1,775629 1,753634 1,630648 a,b .04
Total corpus callosum 3,016670 3,138682 2,8836115 .19
Hippocampus 4,306658 4,180668 4,083695 .12
Amygdala 1,706626 1,716631 1,650643 .44
Caudate 3,771689 3,8686105 3,9876146 .44
Putamen 6,1456106 6,1206125 6,1826174 .96
Accumbens 696619 699623 756632 .24
Abbreviation. HC: healthy controls; T1C: diabetic controls; WFS: Wolfram Syndrome group; SEM: standard error of the mean.
P values shown are for the main effect of group in univariate GLM analyses for each measure.
Values in bold survived Bonferroni correction for multiple comparisons (p,.0038).
adifferent from HC group; bdifferent from T1C group.
doi:10.1371/journal.pone.0040604.t003
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Figure 1. Regional subcortical brain volumes by significance level. Regions were segmented in Freesurfer. Left and right volumes were
averaged and are shown on the right side of the brain only. The brainstem, cerebellar gray matter and cerebellar white matter were significantly
reduced in the WFS compared to controls and survived Bonferroni multiple comparison correction (in red; p,.0038). In addition, the thalamus and
pallidum were also reduced in WFS compared to controls, but did not survive correction (p,.05, in yellow). Finally, the corpus callosum,
hippocampus, amygdala, caudate, putamen and accumbens were not different between groups (p..05, in purple).
doi:10.1371/journal.pone.0040604.g001
Figure 2. Volume of brainstem segments by diagnosis and age. (A) The WFS group has reduced volumes in all three brainstem segments
after adjusting for intracranial volume. A repeated measures general linear model analysis found a segmental volume by diagnosis interaction
(F(4,112) = 7.6, p,.001). Volume in the WFS group was significantly different from the control groups for all three segments (*), but the effect was
most striking in the pons. (B) The pons appeared to be reduced in volume in almost all WFS individuals even after adjusting for intracranial volume.
This figure shows the relationship between pontine volume and age. HC = healthy controls; T1C = diabetic controls; WFS = Wolfram group.
doi:10.1371/journal.pone.0040604.g002
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Figure 3. Regions with cortical thinning in the WFS group. After multiple comparison correction and adjustment for age and gender, (A and B)
the rostral middle frontal cortex was found to be thinner bilaterally (right cluster-wise p = .001; left cluster-wise p= .0001 and p= .0304), as was (B) the
left precentral (cluster-wise p = .0008) and (C) the left lingual (cluster-wise p = .0113) cortex.
doi:10.1371/journal.pone.0040604.g003
Figure 4. Voxel-based morphometry (VBM) findings. Gray and white matter clusters where WFS have lower volumes than controls. (A) Gray
matter clusters included right cerebellum (p = .0008), and left cerebellum (p= .0125), while (B) white matter clusters included a large cluster consisting
of much of the cerebellum, brainstem, and subcortex (p,.001), and a small cluster in the parietal-occiptal cortex (p = .0239). Glass brain (all results
shown collapsed on a single slice) view shown on left, and the significant cluster on an average MR overlay is shown on the right. Cross hairs are
placed in the voxel with a peak t value in the cluster.
doi:10.1371/journal.pone.0040604.g004
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affects brain development both globally and preferentially, even at
the earliest stages of symptoms. Previous clinical retrospective
survey studies suggested that neurological features occur later (15–
30 yrs of age) in the disease process [32,33], which led to the
assumption that brain changes in WFS also occur later and are
neurodegenerative in nature. Our findings, based on direct,
objective and quantified measures of brain structure and function,
counter this assumption by showing abnormalities at the onset of
classic WFS symptoms (diabetes and optic nerve atrophy), are
consistent with abnormal neurodevelopment, and so represent a
significant new insight into the WFS disease process.
Our observation that individuals with WFS have significantly
reduced ICV, in comparison to both diabetics and healthy
controls, supports the concept of aberrant neurodevelopment in
WFS. The major expansion of the cranial vault is driven by brain
growth early in childhood until all of the cranial sutures fuse
(around age 6), at which point ICV changes only very slowly
[67,68]. Skull maturation is 77% complete by age 2 [69], 90%
complete by age 6 [68], and maximum growth is achieved at about
10–13 years of age [70]. ICV is therefore considered to be a
reflection of how fully the brain grew and matured in childhood
[71]. For example, neurodevelopmental studies of autism [72],
Rett Syndrome [73], and childhood onset multiple sclerosis [74]
have interpreted differences in ICV or head circumference
between patient and control groups as an indication of abnormally
accelerated or decelerated brain growth during development. In
both autism and Rett Syndrome, individuals fall within the normal
range at birth, but within the first two years of development their
brain growth rapidly diverges from the normal trajectory, and the
degree of divergence correlates with the core symptoms of the
disorders [72,73]. Based on the literature, we suspect that the
reductions in ICV between our WFS group and both the diabetic
and healthy control groups may indicate that WFS affects the
brain early in the course of development. We did not see
differences in whole brain volume once we corrected for reduced
ICV, which is evidence against global brain degeneration.
The preferential vulnerability of the brainstem and cerebellum
in WFS has been described previously, generally in adults in
advanced disease states, without quantification or control groups
[1,3,21–31,75,76]. These qualitative findings typically have been
interpreted as reflecting a neurodegenerative rather than a
neurodevelopmental process [21]. Our study quantifies this
preferential vulnerability across multiple imaging modalities and
analysis approaches (VBM, Freesurfer regions, DTI regions of
interest, TBSS) and at a very young age. Our data clearly indicate
that brainstem and cerebellum volume abnormalities are present
at the time of the very earliest clinical manifestations of WFS (e.g.
0.5 years of diabetes). In combination with the ICV results, this
novel observation suggests that the brain may be affected in WFS
from a very early stage. Interestingly, the cerebellum and the
brainstem follow a very early, prolonged and neurobiologically-
linked course of development in humans [77], which is thought to
make them more susceptible to neurodevelopmental disorders
[78]. Longitudinal follow-up of our cohort will be critical in
determining if individuals show further changes within these
structures relative to normal developmental trajectories and at
what stage of disease severity.
In addition to these profound subcortical and cerebellar
changes, we also found relatively isolated cortical effects of WFS.
Cortical thickness was reduced in WFS in restricted regions,
including lingual, precentral, and rostral middle frontal cortex.
These cortical regions are associated with vision, motor function
and higher order cortical functions such as working memory,
respectively. These regions are known to reduce in thickness with
age during middle childhood, and be influenced by genetic factors
[79]. In addition, both increased [80] and decreased thickness can
be seen in neurodegeneration and neurodevelopmental conditions
[81–83]; however, mechanistic interpretations of this finding are
unclear. Furthermore, other metrics, such as cortical area and
volume did not reveal any significant effects, suggesting that
cortical differences in early WFS are much more subtle and
restricted than cerebellar and brainstem changes.
Our complementary, quantitative measurements of structural
brain differences in WFS allow us to build hypotheses about
potential underlying mechanisms. For example, we found
reduced fractional anisotropy and reduced axial (but not radial)
diffusivity in the brainstem, cerebellum, optic radiations and
numerous other regions. Radial diffusivity, the diffusion of water
perpendicular to white matter fibers, is known to increase in
response to myelin damage [84–86]. In contrast, fractional
anisotropy, the overall directionality of water movement, and
axial diffusivity, the diffusion of water parallel to white matter
fibers, is known to decrease in response to axonal damage [87–
92]. Thus, it is reasonable to conclude that the differences
observed in the WFS group’s white matter microstructure reflect
Table 4. Mean (6SEM) DTI measures from selected brain









Cerebellum FA .236.004 .226.01 .186.01 a,b ,.001
MD .706.01 .666.02 .776.01 a,b ,.001
Optic
Radiation
FA .556.01 .506.02 a .476.02 a ,.001
MD .846.01 .816.02 .876.02 .20
Corpus
callosum
FA .746.01 .776.01 .716.01 b .009
MD .806.01 .726.03 .80602 b .03
PLIC FA .686.01 .696.01 .686.01 .68
MD .696.01 .666.01 a .686.01 .04
Centrum
semiovale
FA .336.01 .386.02 .356.02 .12
MD .846.02 .756.05 .766.05 .11
Thalamus FA .316.01 .306.02 .306.02 .47
MD .756.01 .736.02 .736.01 .19
Putamen FA .136.004 .136.01 .146.01 .86
MD .716.004 .696.01 .696.01 .06
Hippocampus FA .176.01 .166.01 .146.01 .10
MD .886.03 .856.06 .976.05 .22
Cerebellar
peduncle
FA .566.02 .606.03 .576.03 .57
MD .676.01 .636.02 .666.02 .08
Pons FA .456.01 .426.02 .406.02 a .03
MD .726.01 .746.02 .716.02 .65
Abbreviation. HC: healthy controls; T1C: diabetic controls; WFS: Wolfram
Syndrome group; SEM: standard error of the mean; PLIC: posterior limb of the
internal capsule.
P values shown are for the main effect of group in univariate GLM analyses for
each measure.
Values in bold survived Bonferroni correction (p,.005) for multiple
comparisons.
adifferent from HC group; bdifferent from T1C group.
doi:10.1371/journal.pone.0040604.t004
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either axonal damage or impaired axonogenesis. Although
neuropathological case reports have also suggested loss of
myelinated axons in these regions, it has not always been clear
if these are degenerative or developmental changes [21,76].
While WFS has previously been considered a neurodegenera-
tive disease, it is also possible that the brain abnormalities reported
in WFS are the product of two separate pathological processes,
one that is neurodevelopmental in nature and the other
neurodegenerative. Another possibility is that although there are
early brain changes, these do not produce neurological symptoms
until later in development, due to compensatory processes or the
fact that the involved brain networks and functions do not come
on-line until later [93]. For example, in our study and in others,
the MRI and neuropathological changes observed appear more
severe than the neurobehavioral findings would suggest [27,30].
The apparent lack of cognitive deficits in our cohort in the context
of highly atypical brain volumes (e.g. brainstem and cerebellum)
could indicate compensatory processes or the lack of involvement
of these regions in higher order cognitive processing. Notably, we
found that many of these subjects have ataxia which has been
associated with cerebellar dysfunction in other developmental
populations [94]. Longitudinal follow-up of our cohort, and the
addition of even younger and earlier, pre-symptomatic WFS
patients will be essential for determining the difference between
neurodevelopmental and neurodegenerative processes.
Our cohort also had notable depression and anxiety, similar to
findings in advanced WFS [95] and anxiety behaviors found in
animal models of WFS (wfs1-deficient mice) [96]. While cerebellar
dysfunction has also been associated with altered mood [97], we
cannot currently distinguish whether these symptoms are a
reaction to living with a chronic, degenerative condition or if
they are part of the disease process itself. Our findings suggest the
need for psychiatric assessment and possibly treatment even in the
early stages of WFS. Tracking changes in mood and anxiety will
be an important component of future research.
The major strength of this study is its quantification of regional
brain abnormalities in a group of WFS individuals with a range of
disease severity, from newly diagnosed to more significantly
affected. Although the WFS sample presented here is small
compared to studies of more common neurodegenerative diseases,
it is the largest quantified neuroimaging study of WFS to date.
Furthermore, we compare our WFS to two larger groups of age
and gender equivalent comparison groups, to control for any
effects of diabetes or normal development on the brain, and we
applied multiple comparison corrections. However, there are some
limitations to our study. Since our study design was cross-sectional,
we cannot be sure that the observed age-independence of certain
effects would be confirmed in a longitudinal within-subjects design.
Control subjects were a convenience sample obtained from several
current studies at WUSM, and thus did not have cognitive/
behavioral testing. Although all WFS participants who were
willing to travel to St. Louis were accepted into the study, this
requirement may have selected for individuals who were higher
functioning than the general WFS population. The T1C subjects
with DTI scans had shorter duration of diabetes than our WFS
subjects. Ideally, groups would be matched on this variable and on
degree of hyperglycemia and hypoglycemia exposure. Based on
our experience and the existing literature, however, we feel that it
is highly unlikely that small differences in duration of diabetes
would cause the dramatic differences seen between WFS and the
control groups (T1C and healthy). In all of the previous
neuroimaging studies of T1C, including those in youth [98,99]
and in adults with much longer duration and extreme exposure to
hyperglycemia and hypoglycemia [100,101], none have found the
pattern of dramatically reduced brainstem and cerebellar volumes
seen here in the WFS. Groups also had slight differences in the
sequences and scanners used, although these relatively minor
differences would not be expected to explain the dramatic findings
in our WFS group. Furthermore, when the data analyses were
restricted to only those subjects scanned on the same machine
using identical sequences, our findings remained highly significant.
The results of this study lay the groundwork for larger,
longitudinal investigations of neuroanatomical changes in WFS
which could confirm and extend our observations, and distinguish
Figure 5. Results from tract-based spatial statistics (TBSS) analysis. Fractional anisotropy (FA) and axial diffusivity (AD), but not radial
diffusivity, were reduced in the WFS group compared to controls (healthy and diabetic control groups combined), even after multiple comparison
correction. There were no significant findings in the opposite direction (WFS . controls). White matter tracts in the cerebellum, brainstem, and optic
radiations were prominently affected, but changes were also noted in other areas as well. The multiple comparison corrected p values are
represented in the color coding. Z = the Talairach coordinate for the transverse plane.
doi:10.1371/journal.pone.0040604.g005
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between earlier vs. later occurring abnormalities. In addition, the
behavioral correlates of neuroanatomical changes will need to be
better understood. For example, functions known to be reliant on
the optimal development of the cerebellum and brainstem, such as
gait and balance, should be better characterized. Longitudinal
measurement of this cohort of individuals with WFS is ongoing
and will need to be significantly expanded to answer these
important clinical questions. Nevertheless, our current data
provide fundamental insight into the neurophenotype associated
with WFS and provide the necessary information for determining
the appropriateness of animal models of WFS for understanding
the neurobiological mechanisms underlying these findings and for
developing neurologically-targeted interventions. This work would
also contribute to our understanding of the impact of ER stress-
related dysfunction during development.
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